Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05145387 · ClinicalTrials.gov registry record · NA
Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS)
A NA study of Anxiety Disorders, sponsored by UConn Health.
- Active
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05145387 is a NA study of Anxiety Disorders that is active but no longer recruiting, run by UConn Health. The registered enrollment target is 32 participants, below the 1,140-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05145387, a NA study of Anxiety Disorders, is active but no longer recruiting, sponsored by UConn Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Excessive anxiety is a common problem that severely impairs short and long term academic functioning. The transition to middle school (MS) results in increases in anxiety and decreases in academic functioning. Students with anxiety in particular, due to their vulnerability to school-based stressors, are at risk for social, emotional and academic failure during the transition to MS. Unfortunately, the majority of these students do not get identified. Reducing student anxiety has been associated with improvement in academic functioning. Because the transition to MS is inevitable, targeting students with excessive anxiety will help their adjustment to their new school setting, reducing the need for special education and mental health counseling. No interventions exist to help these students with this transition. This study aims to: (1) develop and assess the feasibility of a brief, multi-component intervention, referred to as TEAMSS, Transitioning Emotionally and Academically to Middle School Successfully, to reduce anxiety and improve academic functioning through the transition to MS using an iterative development process (i.e., expert review, two open trials, and small randomized controlled trial (RCT)); (2) conduct a pilot RCT comparing the preliminary impact of TEAMSS, relative to enhanced usual care (EUC), in improving students' social, behavioral, and academic functioning through the transition to MS; and (3) examine theory-based mediators, predictors, and moderators of TEAMSS and assess intervention costs.
Conditions Studied
Interventions
- BEHAVIORAL Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS)
Study Locations (1)
Connecticut
- UConn Health - West Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-02-08 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05145387
The ClinicalTrials.gov registry entry for NCT05145387 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (97% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS) is the first listed.
NCT05145387 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05145387 about?
NCT05145387 is a clinical study titled "Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS)". Excessive anxiety is a common problem that severely impairs short and long term academic functioning. The transition to middle school (MS) results in increases in anxiety and decreases in academic functioning. Students with anxiety in particular, due to their vulnerability to school-based stressors,...
What is the current status of trial NCT05145387?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-02-08. Estimated completion is 2026-07-30.
What conditions does trial NCT05145387 study?
This clinical trial studies the following conditions: Anxiety Disorders.
What interventions are being tested in trial NCT05145387?
The interventions under investigation include: Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05145387?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05145387 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.